Tofisopam is a prescription medicine in some countries and is not interchangeable with all other benzodiazepine-family medicines simply because of chemical classification. Its inactive ingredients depend on the marketed product and local authorization.
The Japanese PMDA package insert for Grandaxin 50 mg tablets describes tofisopam as the active ingredient and lists microcrystalline cellulose, lactose hydrate, dibasic calcium phosphate granules, carmellose calcium and magnesium stearate as additives.
What the Ingredient Name Actually Means
A useful ingredient guide begins by separating the identity of the named substance from the composition of the finished product. In a pharmaceutical context, the label may include processing aids, carriers, stabilizers and colorants that are not part of the molecular identity of the main substance. Treating those separate functions as if they were a single chemical ingredient can mislead readers.
This distinction is especially important when a product is described by a familiar short name rather than a full ingredient panel. A capsule, coated tablet, powder, food preparation or injectable solution is a manufactured dosage or product form. Its formula is determined by a manufacturer, and the exact components may differ from another formulation with a similar front label.
Ingredient List and Functional Roles
The following components are relevant to the specific example or formulation context described in this article. They are not an assertion that every similarly named product includes each of these materials.
| Ingredient or material | Role or identification |
|---|---|
| Tofisopam | Active drug substance |
| Microcrystalline cellulose | Tablet filler or binder |
| Lactose hydrate | Filler |
| Dibasic calcium phosphate granules | Formulation bulk |
| Carmellose calcium | Disintegrant |
| Magnesium stearate | Tablet lubricant |
Tofisopam
Active drug substance. Its presence on a declared label should be interpreted in relation to the whole product, not as proof that the same material appears in every brand or strength. Where the ingredient contributes to manufacturing or stability, it should not be confused with the principal active or nutritional substance.
Microcrystalline cellulose
Tablet filler or binder. Its presence on a declared label should be interpreted in relation to the whole product, not as proof that the same material appears in every brand or strength. Where the ingredient contributes to manufacturing or stability, it should not be confused with the principal active or nutritional substance.
Lactose hydrate
Filler. Its presence on a declared label should be interpreted in relation to the whole product, not as proof that the same material appears in every brand or strength. Where the ingredient contributes to manufacturing or stability, it should not be confused with the principal active or nutritional substance.
Dibasic calcium phosphate granules
Formulation bulk. Its presence on a declared label should be interpreted in relation to the whole product, not as proof that the same material appears in every brand or strength. Where the ingredient contributes to manufacturing or stability, it should not be confused with the principal active or nutritional substance.
Differences Between Finished Products
This is a documented example from a Japanese product. Products in other markets can have different formulations, trade names or strengths; ingredient information should never be generalized from the word tofisopam alone.
When comparing two labels, start with the route and form of the product. Then look for separate declarations for the core, coating, capsule shell, liquid vehicle or food matrix. A formula copied from an unrelated strength or manufacturer can give the wrong answer to a question about allergies, dietary ingredients or specific additives.
A product can also change its supplier, package, strength or formulation over time. For that reason, ingredient documentation is most reliable when tied to the exact package and its most recent official label. Historical labels help explain differences but do not replace current product information.
Generic Names, Brands and Ingredient Lists
A generic chemical or ingredient name tells a reader what the substance is, while a commercial product name usually identifies a specific presentation. Our guide to generic versus brand-name drugs illustrates why medicines with the same active ingredient can still use different nonactive materials. Food additives, dietary supplements and cosmetic ingredients are subject to different regulatory frameworks, so pharmaceutical generic equivalence should not be assumed for those categories.
This is a practical editorial distinction: knowing that two products contain the same principal substance does not establish that their inactive ingredient lists, manufacturing methods or product claims are interchangeable. Comparisons should cite the actual formulation and avoid treating a product-family name as a universally fixed recipe.
Special Labeling and Formulation Considerations
An ingredient listed as lactose hydrate may matter to readers who compare excipients, but a chemical ingredient list alone cannot establish a product is clinically appropriate for an individual.
The order and terminology of ingredients can also vary with the applicable labeling system. Drug labels typically distinguish active from inactive ingredients; food labels focus on composition and applicable additive declarations; supplements may use a Supplement Facts panel plus an Other Ingredients statement. Reading the wrong type of panel can lead to incorrect conclusions.
The amount of an ingredient often matters as much as its name. Some product labels provide quantitative strengths for active components but only name inactive ones. Do not infer an excipient dose or safety threshold from a qualitative ingredient list, or transfer an amount from one product to another.
How to Verify the Exact Product
Regulatory status and product availability must be verified in the country where the medicine is supplied.
The primary source for this topic is Japan PMDA tofisopam label. It should be used as a starting point for checking the stated formulation, while the current labeling and local regulatory record for the exact product remain decisive.
- Identify the product name, manufacturer, strength and product form.
- Confirm the official or manufacturer-issued label for that precise presentation.
- Read the full inactive-ingredient section, including capsule shells and coatings where applicable.
- Separate the active chemical or nutrient from the carrier and processing aids.
- Recheck the ingredient panel if the product or market changes.
Common Questions
Does this ingredient name reveal the complete formulation?
No. A substance name identifies a component. The full list of substances in a finished product depends on the formulation and should be verified on the applicable label.
Are ingredient lists identical across all manufacturers?
Not necessarily. Two products can share the same principal substance while using different carriers, fillers, solvents, pigments or processing aids.
Does an inactive ingredient mean it has no practical significance?
No. Inactive is a pharmaceutical classification distinguishing the active drug from formulation substances. An excipient may still be important for manufacturing, allergy screening or product compatibility.
Can a label from another country be used as the local formulation?
Only as an example. Ingredients and regulatory status may differ by jurisdiction; use the document for the exact country and presentation.
Where should an ingredient question be verified?
Start with a current authorized product label, manufacturer specification or relevant regulator database. A generic overview should never substitute for an exact product ingredient statement.
Conclusion
Tofisopam is a prescription medicine in some countries and is not interchangeable with all other benzodiazepine-family medicines simply because of chemical classification. The most dependable way to understand the complete composition is to distinguish the named main substance from the additives of the finished product and cross-check each claimed component against the relevant label.
Ingredient lists are useful reference tools, but they are product-specific. They do not establish whether a medicine is appropriate for a particular person, whether products are clinically interchangeable, or whether a food or supplement has an independently demonstrated benefit.
This article provides ingredient and labeling information, not personal medical advice.